KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Sales (2016 - 2025)

Historic Return on Sales for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to 0.34%.

  • Amgen's Return on Sales changed 0.0% to 0.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.12% for FY2024, which is 1200.0% down from last year.
  • Latest data reveals that Amgen reported Return on Sales of 0.34% as of Q3 2025, which was down 0.0% from 0.16% recorded in Q2 2025.
  • Amgen's Return on Sales' 5-year high stood at 0.47% during Q1 2023, with a 5-year trough of 0.02% in Q1 2024.
  • Its 5-year average for Return on Sales is 0.22%, with a median of 0.24% in 2022.
  • Per our database at Business Quant, Amgen's Return on Sales skyrocketed by 2300bps in 2023 and then plummeted by -4800bps in 2024.
  • Quarter analysis of 5 years shows Amgen's Return on Sales stood at 0.28% in 2021, then decreased by -15bps to 0.24% in 2022, then plummeted by -60bps to 0.09% in 2023, then decreased by -26bps to 0.07% in 2024, then soared by 388bps to 0.34% in 2025.
  • Its Return on Sales stands at 0.34% for Q3 2025, versus 0.16% for Q2 2025 and 0.21% for Q1 2025.